Global Injectable Drug Delivery Devices Market to grow at a CAGR of 6.12% by 2032, Evaluates DelveInsight

According to DelveInsight's analysis, The intraocular lens market is witnessing significant growth due to the rising prevalence of eye disorders such as cataracts, presbyopia, and astigmatism, which are driving demand for corrective surgeries. This trend is supported by greater awareness and improved access to eye care services, particularly in developing regions, allowing more patients to pursue treatment. Advances in lens materials and designs-including multifocal, toric, and extended depth-of-focus lenses-are improving visual outcomes and patient satisfaction. Additionally, increased product development efforts by leading market players are introducing innovative, customized IOL solutions, collectively fueling the global intraocular lens market's expansion from 2025 to 2032.

DelveInsight's "Injectable Drug Delivery Devices Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Injectable Drug Delivery Devices companies actively working in the market.

To know more about why North America is leading the market growth in the Injectable Drug Delivery Devices market, get a snapshot of the report Injectable Drug Delivery Devices Market Trends
https://www.delveinsight.com/sample-request/injectable-drug-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Injectable Drug Delivery Devices Overview
Injectable Drug Delivery Devices are medical tools designed to administer medications directly into the body through the skin, muscles, or veins. These devices include syringes, auto-injectors, prefilled syringes, and pen injectors, which ensure accurate dosing, ease of use, and improved patient compliance. They are commonly used for vaccines, insulin, biologics, and other therapies that require rapid or controlled delivery. Modern injectable devices often incorporate safety features, ergonomic designs, and sometimes digital connectivity to enhance patient monitoring and reduce the risk of errors or needle-stick injuries.

DelveInsight Analysis: The global intraocular lens market was estimated at USD 4,648.96 million in 2024 and is projected to grow at a CAGR of 6.12% from 2025 to 2032, reaching approximately USD 7,414.66 million by 2032.

Injectable Drug Delivery Devices Market Insights
Geographically, North America is expected to hold the largest share of the intraocular lens market in 2024. This growth is fueled by a high concentration of eye care professionals and clinics, including optometrists, ophthalmologists, and specialized eye centers, a substantial patient population affected by vision disorders such as hypermetropia, astigmatism, and vision loss, a well-developed healthcare infrastructure, and ongoing product development initiatives. Collectively, these factors are anticipated to drive the expansion of the intraocular lens market in the region throughout the forecast period from 2025 to 2032.

To read more about the latest highlights related to Injectable Drug Delivery Devices, get a snapshot of the key highlights entailed in the Injectable Drug Delivery Devices
https://www.delveinsight.com/report-store/injectable-drug-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Recent Developments in the Injectable Drug Delivery Devices Market Report
• In October 2024, Bausch + Lomb Corporation, a global leader in eye health dedicated to enhancing vision and quality of life, announced that the U.S. Food and Drug Administration has approved the enVista® EnvyTM full-range-of-vision intraocular lens (IOL).
• In July 2022, The AptheraTM Intraocular Lens (IOL) secured FDA approval, achieving multiple notable milestones in the industry. It is the first small-aperture IOL to receive FDA clearance, the first lens approved for implantation alongside a monofocal or monofocal toric IOL in the opposite eye, and the first extended depth-of-focus (EDOF) lens indicated for monovision. Additionally, it is the first non-toric IOL authorized for cataract patients with low corneal astigmatism, marking a significant advancement in personalized cataract care.
• Thus, owing to such developments in the market, rapid growth will be observed in the Injectable Drug Delivery Devices market during the forecast period

Key Players in the Injectable Drug Delivery Devices Market
Some of the key market players operating in the Injectable Drug Delivery Devices market include- Johnson & Johnson Services, Inc., Hoya Corporation, ALCON INC., ZEISS Group, Rayner Intraocular Lenses Limited, Eyekon Medical Inc., Lenstec, Inc., HumanOptics AG, STAAR Surgical Company, Aurolab, PhysIOL SA, Care Group, TEKIA, Inc., Omni Lens Pvt Ltd., MORCHER® GmbH, Ophtec BV, SIFI S.p.A., Excellent Hi-Care Pvt Ltd., Bausch & Lomb Incorporated, Hanita Lens, and others.

Which MedTech key players in the Injectable Drug Delivery Devices market are set to emerge as the trendsetter explore @ Key Injectable Drug Delivery Devices Companies
https://www.delveinsight.com/sample-request/injectable-drug-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Analysis on the Injectable Drug Delivery Devices Market Landscape
The growing prevalence of vision disorders such as astigmatism, hypermetropia, and general visual impairment is driving increased demand for intraocular lenses (IOLs). As awareness of eye health rises, more people are seeking corrective procedures, particularly through cataract and refractive surgeries, to restore or enhance vision. This heightened demand, coupled with innovations in lens design and a focus on early diagnosis and preventive eye care, is supporting steady growth in the IOL market.
Moreover, ongoing product development by key players and regulatory advancements is expected to further propel market expansion. For instance, in October 2024, Johnson & Johnson (J&J) announced the broader availability of its TECNIS Odyssey intraocular lens across the United States.

Scope of the Injectable Drug Delivery Devices Market Report
• Coverage: Global
• Study Period: 2022-2032
• Injectable Drug Delivery Devices Market Segmentation By Type: Monofocal IOL (Aspheric Monofocal IOLs and Spheric Monofocal IOLs
• Injectable Drug Delivery Devices Market Segmentation By Premium IOLs: Multifocal IOLs, Accommodating IOLs, and Extended Depth-Of-Focus (EDoF) IOLs), and Others), Intraocular Lens Market by Material (Polymethyl Methacrylate (PMMA), Hydrophobic Acrylic IOLs, Hydrophilic Acrylic IOLs, and others
• Injectable Drug Delivery Devices Market Segmentation By Material: Polymethyl Methacrylate (PMMA), Hydrophobic Acrylic IOLs, Hydrophilic Acrylic IOLs, and Others
• Injectable Drug Delivery Devices Market Segmentation By End User: Hospitals, Ambulatory Surgical Centres and Ophthalmology Clinics
• Injectable Drug Delivery Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Injectable Drug Delivery Devices Companies: Johnson & Johnson Services, Inc., Hoya Corporation, ALCON INC., ZEISS Group, Rayner Intraocular Lenses Limited, Eyekon Medical Inc., Lenstec, Inc., HumanOptics AG, STAAR Surgical Company, Aurolab, PhysIOL SA, Care Group, TEKIA, Inc., Omni Lens Pvt Ltd., MORCHER® GmbH, Ophtec BV, SIFI S.p.A., Excellent Hi-Care Pvt Ltd., Bausch & Lomb Incorporated, Hanita Lens, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.